Galecto
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galecto and other ETFs, options, and stocks.About GLTO
Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2.
CEOHans Thalsgård Schambye
CEOHans Thalsgård Schambye
Employees5
Employees5
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2011
Founded2011
Employees5
Employees5
GLTO Key Statistics
Market cap4.26M
Market cap4.26M
Price-Earnings ratio-0.21
Price-Earnings ratio-0.21
Dividend yield—
Dividend yield—
Average volume24.28K
Average volume24.28K
High today$3.28
High today$3.28
Low today$3.16
Low today$3.16
Open price$3.17
Open price$3.17
Volume4.00K
Volume4.00K
52 Week high$16.07
52 Week high$16.07
52 Week low$2.01
52 Week low$2.01
People also own
Based on the portfolios of people who own GLTO. This list is generated using Robinhood data, and it’s not a recommendation.